Literature DB >> 3872331

The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells.

R S Accolla, G Carra, F Buchegger, S Carrel, J P Mach.   

Abstract

The expression of Ia-associated human Invariant (In) chain glycoproteins was studied in the Raji B cells as well as in their RJ 2.2.5 Ia-negative derived variant cells by using a specific rabbit anti-human In chain antiserum. Two-dimensional gel electrophoresis of immunoprecipitates from either biosynthetically labeled or surface labeled cells were analyzed. In addition, flow microfluorometric analysis of stained cells was performed. The results indicate that the In chain is constitutively produced in the Ia-negative B cell variant. Moreover, it appears that several forms of In chain-related molecules, with different charges and distinct m.w. are equally expressed in Ia-positive and Ia-negative B cells. Finally, no evidence could be obtained that the In molecular family was expressed on the cell surface of Ia-positive Raji and Ia-negative RJ 2.2.5 cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872331

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.

Authors:  M S Anderson; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 2.  A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.

Authors:  R S Accolla; P Dellabona; L Scarpellino; G Carra; S Sartoris
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis.

Authors:  P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 4.  Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells.

Authors:  Farah Bou Nasser Eddine; Elise Ramia; Giovanna Tosi; Greta Forlani; Roberto S Accolla
Journal:  Oncoimmunology       Date:  2017-07-31       Impact factor: 8.110

5.  Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes.

Authors:  C Doyle; P J Ford; P D Ponath; T Spies; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Role for intracellular proteases in the processing and transport of class II HLA antigens.

Authors:  J S Blum; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 7.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

8.  Three distinct signals can induce class II gene expression in a murine pre-B-cell line.

Authors:  B S Polla; A Poljak; S G Geier; S G Nathenson; J Ohara; W E Paul; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Polysaccharide processing and presentation by the MHCII pathway.

Authors:  Brian A Cobb; Qun Wang; Arthur O Tzianabos; Dennis L Kasper
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

10.  Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.

Authors:  A J Sant; S E Cullen; K S Giacoletto; B D Schwartz
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.